Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 445,500 shares, an increase of 23.8% from the July 31st total of 359,900 shares. Based on an average trading volume of 190,000 shares, the days-to-cover ratio is presently 2.3 days.
Orgenesis Stock Performance
Shares of ORGS opened at $0.67 on Friday. The firm’s 50-day moving average is $0.71 and its two-hundred day moving average is $0.63. Orgenesis has a twelve month low of $0.25 and a twelve month high of $1.08.
Orgenesis (NASDAQ:ORGS – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.23) earnings per share for the quarter. The business had revenue of $0.25 million for the quarter.
Orgenesis Company Profile
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Featured Articles
- Five stocks we like better than Orgenesis
- Pros And Cons Of Monthly Dividend Stocks
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 8/26 – 8/30
- How to Use Stock Screeners to Find Stocks
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
